NPA’s critical work during the pandemic is a reminder that our association founded in 1936 has a history of supporting its members in good times and in bad times.

FDA is proposing to require the submission of GRAS notices for human and animal food substances. NPA is carefully monitoring these developments.

This year’s NPA Fly-In Day was a powerful reminder of why direct advocacy continues to shape the future of dietary supplements, natural products and consumer access to wellness.

AI’s most practical value in regulated manufacturing environments lies in supporting information access, regulatory context and risk-based prioritization.

Updating the definition of “essential” micronutrients may be one of the most important health reforms the Trump administration can make.

NPA board members met last week with congressional offices and White House officials to push for federal preemption, drug-preclusion reform, stable trade policies and stronger support for U.S. innovation.